These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20157291

  • 1. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR.
    Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
    [Abstract] [Full Text] [Related]

  • 2. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.
    Mandolesi G, Grasselli G, Musumeci G, Centonze D.
    Neurol Sci; 2010 Nov; 31(Suppl 2):S255-9. PubMed ID: 20635112
    [Abstract] [Full Text] [Related]

  • 3. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I, Swiątkiewicz M, Zaremba M, Cudna A, Piechal A, Pyrzanowska J, Widy-Tyszkiewicz E, Członkowska A.
    Neuroscience; 2013 Sep 17; 248():690-8. PubMed ID: 23806721
    [Abstract] [Full Text] [Related]

  • 4. Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
    Ziehn MO, Avedisian AA, Dervin SM, O'Dell TJ, Voskuhl RR.
    Lab Invest; 2012 Aug 17; 92(8):1234-45. PubMed ID: 22525427
    [Abstract] [Full Text] [Related]

  • 5. Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ, Geathers JS, Allan KC, Gelbard HA.
    J Neurosci; 2016 Jan 27; 36(4):1336-46. PubMed ID: 26818520
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease.
    Ziehn MO, Avedisian AA, Dervin SM, Umeda EA, O'Dell TJ, Voskuhl RR.
    J Neurosci; 2012 Sep 05; 32(36):12312-24. PubMed ID: 22956822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ, Hammond JW, Li H, Gantz Marker MA, Marker DF, Freeman RS, Gelbard HA.
    eNeuro; 2018 Sep 05; 5(6):. PubMed ID: 30627663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
    Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, Han S, Yin J, He X.
    Cell Death Dis; 2020 May 15; 11(5):377. PubMed ID: 32415059
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    Bonfiglio T, Olivero G, Merega E, Di Prisco S, Padolecchia C, Grilli M, Milanese M, Di Cesare Mannelli L, Ghelardini C, Bonanno G, Marchi M, Pittaluga A.
    PLoS One; 2017 May 15; 12(1):e0170825. PubMed ID: 28125677
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
    Kocovski P, Tabassum-Sheikh N, Marinis S, Dang PT, Hale MW, Orian JM.
    Front Immunol; 2021 May 15; 12():639650. PubMed ID: 34177891
    [Abstract] [Full Text] [Related]

  • 18. Enhanced GABAergic Tonic Inhibition Reduces Intrinsic Excitability of Hippocampal CA1 Pyramidal Cells in Experimental Autoimmune Encephalomyelitis.
    Kammel LG, Wei W, Jami SA, Voskuhl RR, O'Dell TJ.
    Neuroscience; 2018 Dec 15; 395():89-100. PubMed ID: 30447391
    [Abstract] [Full Text] [Related]

  • 19. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
    Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D'Amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni MT, Diamantini A, Butti E, Comi G, Bernardi G, Cecconi F, Battistini L, Furlan R, Martino G.
    J Neurosci; 2009 Mar 18; 29(11):3442-52. PubMed ID: 19295150
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.